Skip to main content Skip to main navigation menu Skip to site footer
Health Science
Published: 2023-10-31

Epidemiological analysis of deaths from inflammatory disease of the female pelvic organs in Brazil between 2013 and 2022

Centro Universitário da Fundação Assis Gurgacz
Centro Universitário da Fundação Assis Gurgacz
Centro Universitário da Fundação Assis Gurgacz
women's health, gynecology, public health

Abstract

Pelvic inflammatory disease (PID) is a syndrome that predominantly affects women of reproductive age and can cause chronic pelvic pain and infertility. The objective of the present study was to carry out an epidemiological survey of PID deaths reported in Brazil. Ecological, time series, quantitative and descriptive study with data from DATASUS between 2013 and 2022. The following variables were collected: ethnicity, age group, place of death, state of occurrence and cause according to the ICD (N70 to N77) . During the period studied, 2163 women died due to some type of PID. The majority (51.2%) were between 50 and 79 years old. The hospital environment was where 90.8% of cases occurred. Regarding skin color, white women were the most affected (46.4%). There was a record in all Brazilian states, with 16 of them showing an increasing rate. The mortality rate due to PID in the country was 1.06 deaths per thousand inhabitants in Brazil and in 10 states the rate was higher than the national rate. Regarding the cause, the data revealed that the largest number of deaths (853) was due to “N73 - Other Female Pelvic Inflammatory Diseases”, which represented 39.5% of the total. It was possible to note that 77.4% of deaths were reported in CIDs whose name includes the word “other” or “unspecified”, which raises concerns regarding the correct diagnosis used.

References

  1. APOSTOLOU, A., CHAPMAN, C., PERSON, M., KEISEL, K., MCCOLLUM, J. Trends in pelvic inflammatory disease among American Indian and Alaska Native women, Indian Health Service 2001–2015. Am J Public Health, v.108, p.1558–1565, 2018.
  2. https://doi.org/10.2105%2FAJPH.2018.304676
  3. BRASIL. Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis – IST, Brasília: Ministério da Saúde, 2022. 211 p.
  4. DARVILLE, T. Pelvic inflammatory disease due to Neisseria gonorrhoeae and Chlamydia trachomatis: immune evasion mechanisms and pathogenic disease pathways. J Infect Dis, v.16, n.224, p.39-46, 2021. https://dx.doi.org/10.1093/infdis/jiab031
  5. FREITAS, M.S., OLIVEIRA, N.B.B., NOGUEIRA, V.D., BRASIL, C.A., GARCIA, L.S., RAMOS, F.G.A., & FIGUEIREDO, M.B.M. Mortalidade por abdome agudo por causas ginecológicas em mulheres em idade fértil e o IDH das regiões brasileiras (2010-2019): um estudo ecológico. Pubsaúde, v. 13, p. a420, 2023.
  6. https://dx.doi.org/10.31533/pubsaude13.a420
  7. GAMBERINI, C., JULIANA, N.C.A., DE BROUWER, L., VOGELSANG, D., AL-NASIRY, S., MORRÉ, S.A., AMBROSINO, E. The association between adverse pregnancy outcomes and non-viral genital pathogens among women living in sub-Saharan Africa: a systematic review. Front Reprod Health, v.7, n.5, p.1107931, 2023.
  8. https://dx.doi.org/10.3389/frph.2023.1107931
  9. GNANADURAI, R., FIFER, H. Mycoplasma genitalium: A Review. Microbiology (Reading), v.166, n.1, p.21-29, 2020.
  10. https://dx.doi.org/10.1099/mic.0.000830
  11. GOMES, S. C., GUIMARÃES, A., BUSETTI, I. C., FANHANI DOS SANTOS, M. S., WEIZEMANN, L. P., HOFFMANN CHEFFER, M. Pré-natal tardio: motivos e intervenções de enfrentamento na Atenção Primária à Saúde. Scientific Electronic Archives, v. 16, n. 6, 2023.
  12. https://dx.doi.org/10.36560/16620231727
  13. HAGGERTY, C.L., NESS, R.B., TOTTEN, P.A. Presence and concentrations of select bacterial vaginosis-associated bacteria are associated with increased risk of pelvic inflammatory disease. Sex Transm Dis, v.47, p.344–6, 2020.
  14. https://doi.org/10.1097/olq.0000000000001164
  15. HILLIER, S.L., BERNSTEIN, K.T., ARAL, S. A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease. J Infect Dis, v.16, n.224, p.23-28, 2021.
  16. https://dx.doi.org/10.1093/infdis/jiab116
  17. HOFFMANN CHEFFER, M., GARCIA RIBEIRO, C., FERRARI DOS SANTOS, A. C., DE OLIVEIRA CALDEIRA, L., PEROTONI KARAS, G., FANHANI DOS SANTOS, M. S., BUSETTI, I. C., FERNANDES DA SILVA, G., BRAMATTI SILVA RAZINI OLIVEIRA, R., WEIZEMANN, L. P. Mortalidade por câncer de colo de útero no Brasil no período de 2010 a 2019. Scientific Electronic Archives, v. 15, n. 8, 2022.
  18. https://dx.doi.org/10.36560/15820221578
  19. HORNER, P., FLANAGAN, H., HORNE, A.W. Is there a hidden burden of disease as a result of epigenetic epithelial-to-mesenchymal transition following Chlamydia trachomatis infection? J Infect Dis, v. 224, p.128–136, 2021.
  20. https://doi.org/10.1093/infdis/jiab088
  21. IBGE – Instituto Brasileiro de Geografia e Estatística. Panorama das cidades brasileiras. Acessado em Julho de 2023.
  22. https://cidades.ibge.gov.br/brasil/pr/panorama
  23. KARANJA-CHEGE, C.M. HPV Vaccination in Kenya: The Challenges Faced and Strategies to Increase Uptake. Front Public Health, v.21, n.10, p.802947, 2022.
  24. https://dx.doi.org/10.3389/fpubh.2022.802947
  25. KREISEL, K., LLATA, E., HAERXHANAJ, L. The burden and trends in pelvic inflammatory disease is the United States, 2006–2016. J Infect Dis, v. 224, p.103–112, 2021.
  26. https://doi.org/10.1093/infdis/jiaa771
  27. LAKATOS, E.M., MARCONI, M.A. Fundamentos de metodologia científica. 9ª Ed. Editora Atlas, 2021.
  28. LINARTEVICHI, V. F., BAGGIO, G. C., KUTZ, D. A. S., SILVA, M. A. M. da., MADUREIRA, E. M. P. Challenges for health professionals in caring for indigenous peoples in Brazil – a review. Research, Society and Development, v. 11, n. 16, p. e303111638156, 2022.
  29. https://dx.doi.org/10.33448/rsd-v11i16.38156
  30. MARCINKOWSKI, K.A., MEHTA, V., MERCIER, R., BERGHELLA, V. Pelvic inflammatory disease in pregnancy: a systematic review focusing on perinatal outcomes. Am J Obstet Gynecol MFM, v.4, n.4, p.100643, 2022.
  31. https://dx.doi.org/10.1016/j.ajogmf.2022.100643
  32. MELKIE, A., DAGNEW, E. Burden of puerperal sepsis and its associated factors in Ethiopia: a systematic review and meta-analysis. Arch Public Health, v.79, n.1, p.216, 2021.
  33. https://dx.doi.org/10.1186/s13690-021-00732-y
  34. MENEZES, M.L.B., GIRALDO, P.C., LINHARES, I.M., BOLDRINI, N.A.T., ARAGÓN, M.G. Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: doença inflamatória pélvica. Epidemiol Serv Saúde, v. 30, s.1, p.e2020602, 2021.
  35. https://doi.org/10.1590/S1679-4974202100011.esp1
  36. OKAZAKI, Y., TSUJIMOTO, Y., YAMADA, K., ARIIE, T., TAITO, S., BANNO, M., KATAOKA, Y., TSUKIZAWA, Y. Diagnostic accuracy of pelvic imaging for acute pelvic inflammatory disease in an emergency care setting: a systematic review and meta-analysis. Acute Med Surg, v.9, n.1, p.e806, 2022.
  37. https://dx.doi.org/10.1002/ams2.806
  38. SATURNINO, A. de F. R., FERREIRA, A. J. S., BRÁZ, A. A. de S., MARTINS, D. de O., BARBOSA, L. N., FONSECA, I. F., DE PAULA, M. G., RESENDE, F. A. O papanicolau como exame de rastreio do câncer de colo de útero e suas implicações na pandemia. Scientific Electronic Archives, v. 16, n. 9, 2023.
  39. https://dx.doi.org/10.36560/16920231730
  40. SILVA, N. B. da, ALESSIO JUNIOR, L. E., TERRA, L. S., LOPES, J. A. S., BRAZ, K. N. D. S., ASSUNÇÃO, G. S. A., SOARES, E. A., ALESSIO, A. M. Comparison of epidemiological profile of leprosy from 2010 to 2020 in the city of Alfenas, state of Minas Gerais, with Brazil. Scientific Electronic Archives, v. 16, n. 10, 2023.
  41. https://dx.doi.org/10.36560/161020231790
  42. SOUZA, C. A. D. de, ANDRADE, I. S., CAVALCANTE, K. M. H. Mortalidade em neonatos residentes no município de Lagarto, nordeste do Brasil. Scientific Electronic Archives, v. 14, n. 6, 2021.
  43. https://dx.doi.org/10.36560/14620211307
  44. TURPIN, R., TUDDENHAM, S., KLEBANOFF, M., GHANEM, K., BROTMAN, R. Bacterial vaginosis and behavioral factors associated with incident pelvic inflammatory disease in the longitudinal study of vaginal flora. J Infect Dis, v.224, p.137–144, 2021.
  45. https://doi.org/10.1093/infdis/jiab103
  46. VETTORAZZI, J., VALÉRIO, E. G., ZANATTA, M. A., SCHEFFLER, M. H., COSTA, S. H. D. A. M., & RAMOS, J. G. L. Evolução temporal da mortalidade materna: 1980-2019. Revista Brasileira de Ginecologia e Obstetrícia, v. 43, p. 662-668, 2021.
  47. https://doi.org/10.1055/s-0041-1735300
  48. VILLELA, D. A. M., & GOMES, M. F. D. C. O impacto da disponibilidade de dados e informação oportuna para a vigilância epidemiológica. Cad. Saúde Pública, v. 38, p. e00115122, 2022.
  49. https://doi.org/10.1590/0102-311XPT115122
  50. XU, S.X., GRAY-OWEN, S.D. Gonococcal Pelvic Inflammatory Disease: Placing Mechanistic Insights Into the Context of Clinical and Epidemiological Observations. J Infect Dis, v. 224, n.12, s.2, p.56-63, 2021.
  51. https://dx.doi.org/10.1093/infdis/jiab227
  52. WHELAN, J., EEUWIJK, J., BUNGE, E., BECK, E. Systematic Literature Review and Quantitative Analysis of Health Problems Associated with Sexually Transmitted Neisseria gonorrhoeae Infection. Infect Dis Ther, v.10, n.4, p.1887-1905, 2021.
  53. https://dx.doi.org/10.1007/s40121-021-00481-z
  54. WIESENFELD, H.C., MEYN, L.A., DARVILLE, T., MACIO, I.S., HILLIER, S.L. A randomized controlled trial of ceftriaxone and doxycycline, with or without metronidazole, for the treatment of acute pelvic inflammatory disease. Clin Infect Dis, v.72, n.7, p.1181–1189, 2020.
  55. https://doi.org/10.1093/cid/ciaa101

How to Cite

Maciel, A. C. A., Batista, A. L. ., & Rymsza, T. . (2023). Epidemiological analysis of deaths from inflammatory disease of the female pelvic organs in Brazil between 2013 and 2022. Scientific Electronic Archives, 16(11). https://doi.org/10.36560/161120231856